Analyst Ratings for scPharmaceuticals
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published bullish opinions on scPharmaceuticals (NASDAQ:SCPH) stock, with an average 12-month price target of $18.5. The average price target has increased by 42.31% over the past month.
June 08, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
4 analysts have published bullish opinions on scPharmaceuticals (NASDAQ:SCPH) stock in the past 3 months, with an average 12-month price target of $18.5, up 42.31% in the past month.
The article mentions that 4 analysts have published bullish opinions on scPharmaceuticals (NASDAQ:SCPH) stock in the past 3 months. The average 12-month price target of $18.5 has increased by 42.31% over the past month, indicating a positive sentiment towards the stock. This could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100